How AstraZeneca shot for the moon — and hit
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When AstraZeneca chief Pascal Soriot said the drugmaker would make $80bn in revenue by 2030, his goal seemed wildly ambitious. It would, after all, entail doubling sales over six years. A year and a half … Read more









